Rekombinanter VEGF Antikörper
Kurzübersicht für Rekombinanter VEGF Antikörper (ABIN7795526)
Target
Alle VEGF Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Expressionssystem
- Mammalian cells
-
Verwendungszweck
- Recombinant Anti-mouse VEGF Monoclonal Antibody (Clone: G6-31), Human IgG1 Fc Silent Kappa
-
Produktmerkmale
- The anti-mouse VEGF Monoclonal Antibody (Clone: G6-31) was produced in mammalian cells.
-
Aufreinigung
- Protein A or G affinity column
-
Reinheit
- >95 % by reducing SDS-PAGE
-
Isotyp
- Fc Silenced, IgG1, kappa
-
-
anti-Vascular Endothelial Growth Factor (VEGF) (AA 27-120) antibody
VEGF Reaktivität: Human, Maus, Ratte, Schwein, Ziege WB, ELISA, IHC (p), FACS, IHC (fro), IF (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) antibodyVEGF Reaktivität: Human, Maus, Ratte, Hund, Schwein, Rind (Kuh), Huhn WB, IHC (p), IF (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) (C-Term) antibodyVEGF Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB11705 unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) antibodyVEGF Reaktivität: Human, Ratte WB, IHC, ELISA, FACS, IP, BR Wirt: Maus Monoclonal A-4-6-1 unconjugated Recombinant Antibody
anti-Vascular Endothelial Growth Factor (VEGF) (AA 27-233) antibodyVEGF Reaktivität: Human WB, IHC, IF Wirt: Maus Monoclonal 4E3 unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) antibodyVEGF Reaktivität: Human, Maus, Schwein WB, IF Wirt: Huhn Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) antibodyVEGF Reaktivität: Human, Maus, Ratte IF Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) antibodyVEGF Reaktivität: Human, Maus, Primate WB, IHC, ELISA Wirt: Maus Monoclonal VG76e unconjugated Recombinant Antibody
anti-Vascular Endothelial Growth Factor (VEGF) (N-Term) antibodyVEGF Reaktivität: Human, Maus WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- > 3 mg/mL
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
-
-
- VEGF (Vascular Endothelial Growth Factor (VEGF))
-
Andere Bezeichnung
- VEGF
Target
-
